borderline significanceP = .049
Proportions of HIV-viremic PWH who had quantifiable neutralization, defined as titers above LOQ at the time point 1 month after diagnosis, trended lower relative to HIV-suppressed PWH and HIV-negative participants for all 3 variants ( Figure 2 F –2 H ); this difference had borderline significance for Delta (had neutralization above LOQ, 56% of HIV-negative participants vs 86% of suppressed and 27% of viremic PWH; P = .049 [χ 2 test]).